Biotech company Clinical Genomics raises US$15 million round led by OneVentures

22 March 2016

Clinical Genomics, a biotechnology company working across the United States and Australia, has closed a US$15 million ($19.7 million) round led by Sydney-based VC firm OneVentures. Dr Paul Kelly, partner at and managing director of OneVentures and former CEO of biotech company Gemini Genomics, will join the company’s board of directors.

Learn More

You may also like

12 January 2021

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

News, Media Release

15 November 2020

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

27 May 2020

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

View All

Ventured. Gained.

Subscribe to our Newsletter.

decor decor decor
decor decor decor decor decor